Literature DB >> 10372303

[Experiences with ambulatory cardiologic phase II rehabilitation].

S Schönstedt1, S Beckmann, W Disselhoff, B Rüssmann.   

Abstract

The phase II cardiac rehabilitation in Germany differs markedly from other European countries and the USA. Most of the patients enter a 3-week full residential program. In contrast we developed an outpatient phase II cardiac rehabilitation program. Since 1979 we treated more than 8,500 patients with different indications (i.e. after myocardial infarction, coronary bypass surgery, valve replacement and reconstruction). Patients with a daily commuting time over 60 minutes are not suitable for outpatient rehabilitation. Our model corresponds to the German intrahospital rehabilitation. The rehabilitation is carried out in 3 weeks offering approximately 66 hours of therapy. Groups of 8 patients with a similar level of physical capacity stay together during the rehabilitation. A comprehensive program with exercise training, physical therapy, psychological support, education in life style changes and risk factor modification has been developed. The compliance of the patients as well as the acceptance by the family are excellent. Long-lasting reduction in LDL cholesterol levels and increments in work-load capacities have been demonstrated. A high percentage of patients returned to work. Cost analysis demonstrates a reduction up to 40% in comparison to the full residential program. Therefore the outpatient phase II cardiac rehabilitation is a good alternative especially in urban areas.

Entities:  

Mesh:

Year:  1999        PMID: 10372303     DOI: 10.1007/bf03042126

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  11 in total

1.  REHABILITATION OF PATIENTS WITH CARDIOVASCULAR DISEASES. REPORT OF A WHO EXPERT COMMITTEE.

Authors:  R A BROWN
Journal:  World Health Organ Tech Rep Ser       Date:  1964

2.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  [Ambulatory vs. inpatient rehabilitation after established myocardial infarct--pro ambulatory rehabilitation].

Authors:  R Rost
Journal:  Z Kardiol       Date:  1998

4.  Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials.

Authors:  N B Oldridge; G H Guyatt; M E Fischer; A A Rimm
Journal:  JAMA       Date:  1988-08-19       Impact factor: 56.272

5.  [Primary results and long-term outcome of an ambulatory, cardiac rehabilitation model (phase II) after myocardial infarct, dilatation treatment and heart operation].

Authors:  D B Gysan; R Heinzler; K Schmidt
Journal:  Z Kardiol       Date:  1997-09

6.  [Ambulatory vs. inpatient rehabilitation after established myocardial infarct--contra ambulatory rehabilitation].

Authors:  L Benesch
Journal:  Z Kardiol       Date:  1998

7.  [Ambulatory rehabilitation after myocardial infarct in Austria].

Authors:  W Benzer; R Bitschnau; L Simma
Journal:  Wien Klin Wochenschr       Date:  1995       Impact factor: 1.704

8.  [Ambulatory rehabilitation of cardiac patients in Switzerland].

Authors:  H Saner; D Pfiffner
Journal:  Wien Klin Wochenschr       Date:  1995       Impact factor: 1.704

Review 9.  [Benefits and risks of physical activity in patient with coronary heart disease].

Authors:  H Gohlke
Journal:  Wien Klin Wochenschr       Date:  1995       Impact factor: 1.704

10.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

View more
  1 in total

1.  Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction.

Authors:  Michael Brehm; F Picard; P Ebner; G Turan; E Bölke; M Köstering; P Schüller; T Fleissner; D Ilousis; K Augusta; M Peiper; Ch Schannwell; B E Strauer
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.